Perrigo CoMEX:PRGON 44 EV-to-FCF is 40.00 as of Jun. 24, 2026, which is 45% above its 10-year median of 27.52. GuruFocus rates MEX:PRGON with a GF Score™ of 44/100 and a GF Value™ of MXN1,468.70. The stock has 4 warning signs investors should review. Among 562 Drug Manufacturers companies, Perrigo Co ranks worse than 71% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Perrigo Co's Enterprise Value is MXN79,711 Mil.
Perrigo Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,993 Mil. Therefore, Perrigo Co's EV-to-FCF for today is 40.00.
The historical rank and industry rank for Perrigo Co's EV-to-FCF or its related term are showing as below:
MEX:PRGON'
s EV-to-FCF Range Over the Past 10 Years
Min: -112.04 Med: 27.52 Max: 1733.64
Current: 42.6
During the past 13 years, the highest EV-to-FCF of Perrigo Co was 1733.64. The lowest was -112.04. And the median was 27.52.
MEX:PRGON's EV-to-FCF is ranked worse than 71% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.11
vs MEX:PRGON: 42.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Perrigo Co's share price for today is MXN557.52.
Perrigo Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-235.901.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Perrigo Co EV-to-FCF Related Terms
Perrigo Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Perrigo Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:PRGON vs AMLX, HROW, ANIP: EV-to-FCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Perrigo Co's EV-to-FCF falls into.
Perrigo Co's current Enterprise Value is MXN79,711 Mil.
Perrigo Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,993 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (MEX:PRGON) has a EV-to-FCF of 40.00 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Perrigo Co and its competitors. This is 45% above median its historical median of 27.52. According to the industry distribution chart, Perrigo Co ranks #399 out of 562 companies in the Drug Manufacturers industry, placing it in the top 71%.
Is Perrigo Co's EV-to-FCF too high?
Perrigo Co's current EV-to-FCF of 40.00 is 45% above median its 10-year median of 27.52. The Drug Manufacturers industry median EV-to-FCF is 20.11. Perrigo Co's value of 40.00 is 98.9% above this industry median. Based on the distribution chart, Perrigo Co ranks #399 out of 562 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Perrigo Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's EV-to-FCF compare to AMLX and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #399 out of 562 companies for EV-to-FCF. This places Perrigo Co in the lower half of its industry. The industry median EV-to-FCF is 20.11. Perrigo Co's value of 40.00 is 98.9% above this benchmark. While the company's 10-year median is 27.52 vs. the industry median of 20.11, Perrigo Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.11, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Perrigo Co's current EV-to-FCF of 40.00 is 98.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current EV-to-FCF is 40.00, which is 45% above median its own 10-year median of 27.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current EV-to-FCF of 40.00. The stock's GF Value™ is MXN1,468.70, compared to a current price of MXN557.52 — trading 62% below its estimated fair value. The current EV-to-FCF is 40.00, which is 45% above median its 10-year median of 27.52 and 98.9% above the Drug Manufacturers industry median of 20.11. Perrigo Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current EV-to-FCF is 40.00 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (MEX:PRGON) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of MXN557.52 is trading 62% below its estimated GF Value™ of MXN1,468.70.
Key valuation signals for MEX:PRGON:
EV-to-FCF: 40.00 (45% above median its 10-year median of 27.52)
GF Value™: MXN1,468.70 vs. price of MXN557.52 (62% below fair value)
Industry Position: 98.9% above the Drug Manufacturers median (#399 of 562)
No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
44GF Score
Get the complete analysis for MEX:PRGON
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PRGON has been successfully added to your 
